The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases:

作者: C. Blandizzi , P. Gionchetti , A. Armuzzi , R. Caporali , S. Chimenti

DOI: 10.1177/03946320140270S101

关键词:

摘要: Immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriatic psoriasis, axial spondyloarthropathies, Crohn's disease, ulcerative colitis and juvenile idiopathic comprise a group of chronic disorders characterized by an immune-mediated pathogenesis. Although at clinical presentation these appear unrelated, they have been recognized to share similar pathogenic mechanisms. Data from epidemiological genetic studies further support the concept that IMIDs are interrelated, can co-occur in same patient susceptibility. The specific aetiologies remain unknown, but all known involve dysregulation immune system, including over-expression pro-inflammatory cytokine tumour necrosis factor (TNF). pivotal role played TNF pathogenesis pathophysiology has documented extensive preclinical investigations, confirmed efficacy anti-TNF biotechnological drugs, etanercept, infliximab adalimumab, therapeutic management disorders. In this narrative review, we discuss available data on TNF-dependent associations among different much remains be discovered about aetiology IMIDs, their common pathological features may explain why successfully targeted drugs. Among these, fully human monoclonal antibody, approved for treatment nine distinct IMID indications it is likely become valuable tool complex cluster

参考文章(215)
Susan Shenoi, Carol A. Wallace, Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis Pediatric Drugs. ,vol. 12, pp. 367- 377 ,(2010) , 10.2165/11532610-000000000-00000
H.G. Nüßlein, Wie früh würden wir Biologika wirklich einsetzen Zeitschrift Fur Rheumatologie. ,vol. 71, pp. 838- 839 ,(2012) , 10.1007/S00393-012-1072-Y
H.-J. Lakomek, A. Krause, „Treat-to-Target“ (T2T) aus der Sicht der stationären Rheumatologie Zeitschrift Fur Rheumatologie. ,vol. 70, pp. 656- 663 ,(2011) , 10.1007/S00393-011-0765-Y
John P Williams, Jonathan A Meyers, Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costs. The American Journal of Managed Care. ,vol. 8, ,(2002)
J. Keffer, L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, G. Kollias, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. The EMBO Journal. ,vol. 10, pp. 4025- 4031 ,(1991) , 10.1002/J.1460-2075.1991.TB04978.X
Boonen A, Mau W, The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis. Clinical and Experimental Rheumatology. ,vol. 27, ,(2009)
Yusuf Aydın, Levent Özçakar, Mehmet Yıldız, Ayşen Akıncı, Liaison between rheumatoid arthritis and ulcerative colitis Rheumatology International. ,vol. 23, pp. 47- 48 ,(2003) , 10.1007/S00296-002-0264-1
M. Gallego-Galisteo, A. Villa-Rubio, E. Alegre-del Rey, E. Márquez-Fernández, J. J. Ramos-Báez, Indirect comparison of biological treatments in refractory rheumatoid arthritis. Journal of Clinical Pharmacy and Therapeutics. ,vol. 37, pp. 301- 307 ,(2012) , 10.1111/J.1365-2710.2011.01292.X
Daniela Cihakova, Noel R. Rose, Pathogenesis of myocarditis and dilated cardiomyopathy. Advances in Immunology. ,vol. 99, pp. 95- 114 ,(2008) , 10.1016/S0065-2776(08)00604-4
Pascale Chomarat, Carole Dantin, Lynda Bennett, Jacques Banchereau, A. Karolina Palucka, TNF skews monocyte differentiation from macrophages to dendritic cells. Journal of Immunology. ,vol. 171, pp. 2262- 2269 ,(2003) , 10.4049/JIMMUNOL.171.5.2262